RCC Highlights From ASCO® GU: Adjuvant Treatment, Immunotherapy, Toxicities, and More

Hot topics in RCC at ASCO GU 2023Подробнее

Kidney Cancer Conference Highlights from ASCO GU 2023Подробнее

Kidney Cancer Conference Highlights from ASCO 2022Подробнее

Introducing immunotherapy again in RCC, adds any benefit? - CONTACT-03 #oncology #cancer #2023Подробнее

GU ASCO 2023 Highlights - OncBrothers (Rohit and Rahul Gosain) with Dr. Petros GrivasПодробнее

The role of ICIs in the adjuvant setting for RCCПодробнее

Current Concepts in Adjuvant Therapy for RCC from ASCO GU 2017Подробнее

Immunotherapy-based combinations for advanced/metastatic renal cell carcinoma: ASCO GU 2023Подробнее

Management of immunotherapy-related adverse events in RCCПодробнее

Kidney Cancer Conference Highlights from ASCO 2023Подробнее

Navigating Evolving Standards of Care in RCC: Novel Targeted and Immunotherapy OptionsПодробнее

ASCO 2023: Highlights and analysisПодробнее

ASCO GU24 special: Assoc. Prof. Barata discusses the results of KEYNOTE-564 and CheckMate-914Подробнее

Drs. Choueiri, Pal, & Zand talk the lastest in #RCC from #ASCO22 - https://bit.ly/38CqllcПодробнее

Highlights in Urologic Oncology From 2022 ASCO GU Cancers SymposiumПодробнее

Current Concepts in Adjuvant Therapy for RCC from ASCO GU 2017Подробнее

Highlights in renal cell carcinoma from ASCO GU 2023 and what to look out for in the futureПодробнее

ASCO GU 2024: immunotherapy highlights in kidney cancerПодробнее